Tag Archives: 110

The use of the patent system for federal research results, 13: The failed middle ground

We’ve looked at the early Federal Security Administration policy on inventions made in federally contracted work–FSA order 110-1, issued in 1952. The government’s policy as set forth in David Lloyd Kreeger’s report for the Attorney General in 1947 was that … Continue reading

Posted in Bayh-Dole, History, Policy, Vannever Bush | Tagged , , , | Comments Off on The use of the patent system for federal research results, 13: The failed middle ground

The use of the patent system for federal research results, 12: Never again a Vannevar Bush

We have been working through FSA order 110-1, an early–pretty much the earliest–federal policy on inventions made in federally funded work. Why? The imp of this policy’s approach to inventions, rights, open access, and patent monopoly haunts subsequent policy discussions … Continue reading

Posted in Bayh-Dole | Tagged , , , , | Comments Off on The use of the patent system for federal research results, 12: Never again a Vannevar Bush

The use of the patent system for federal research results, 9: Exploiting the FSA policy safeguards

The earliest major federal patent policy, FSA policy 110-1–for public health research, no less–sets up a process by which the head of each “constituent unit” of the FSA is to make a determination in each case whether the use of … Continue reading

Posted in Uncategorized | Tagged , , , , , | Comments Off on The use of the patent system for federal research results, 9: Exploiting the FSA policy safeguards

The use of the patent system for federal research results, 8: Exploiting the use of the patent system

FSA policy 110, the first agency attempt at making a policy to deal with inventions made in federally supported public health research, tries to establish a middle ground for the use of patents. While clearly endorsing open access, including royalty-free … Continue reading

Posted in Commons, History, Policy, Sponsored Research, Technology Transfer | Tagged , , , , | Comments Off on The use of the patent system for federal research results, 8: Exploiting the use of the patent system

The use of the patent system for federal research results, 7: Failure of FSA 110-1 to establish a middle ground

Let’s look more carefully at this second possibility beyond the possibility of open access–and where the “generally” in FSA 110-1 gets triggered to make at an attempted middle ground between always open access and full-on use of patents to exclude … Continue reading

Posted in History, Patents, Policy, Sponsored Research | Tagged , , , , , | Comments Off on The use of the patent system for federal research results, 7: Failure of FSA 110-1 to establish a middle ground

The use of the patent system for federal research results, 4: Forman

We are looking slowly at FSA order 110-1, the policy that starts the administrative battle over how federal funding ought to affect company opportunities to profit on matters of public health. The FSA, having insisted that research results should be … Continue reading

Posted in History, Patents, Policy | Tagged , , , , | Comments Off on The use of the patent system for federal research results, 4: Forman

The use of the patent system for federal research results, 3: FSA 110-1 and public interest

Federal policy on inventions made in federally supported research starts in a big way with Federal Security Agency Order 110-1, dated December 30, 1952. Norman Latker, patent counsel for the NIH, in 1978 testimony before Senator Nelson’s subcommittee, identified Order … Continue reading

Posted in Commons, History, Innovation, Open Source, Patents, Policy, Sponsored Research | Tagged , , | Comments Off on The use of the patent system for federal research results, 3: FSA 110-1 and public interest